Serological determination of chromium, cobalt, nickel and molybdenum ions in connection with a functional analysis of patients with surface replacement prothesis.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004575

Enrollment

Registered

2012-12-27

Start date

2013-03-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T84.0 Z96.6

Interventions

Group 1: Patients with resurfacing prosthesis

Serological determination of chromium, cobalt, nickel, and molybdenum ions

Functional analysis and evaluation using a modified Harris HIP score

MRI examination of the periprosthetic soft tissues

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with implanted surface replacement prosthesis type conserve plus from Wright Medical Technology, Inc

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Clinical examination and questioning the function of the prosthesis on the basis of the Harris Hip Score preoperatively and more than 1 year postoperatively.	—

Secondary

Measure	Time frame
Serological determination of chromium, cobalt, nickel, and molybdenum ions in patients with more than 1 year of implanted surface replacement prosthesis, and MRI examination of the hip joint with the question of existence of a pseudo tumor.	—

Countries

Germany

Contacts

Public ContactPatrick Schulte

Klinik für Orthopädie der Universität Duisburg-Essen

patrick.schulte@uk-essen.de0201/4089-2261 oder 0201/723-3181

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026